References
- Falcone T, Lebovic DI. Clinical management of endometriosis. Obstet Gynecol 2011;118:691–705
- Leyland N, Casper R, Laberge P, Singh SS. Endometriosis: diagnosis and management. J Obstet Gynaecol Can 2010;32:S1–32
- Mounsey AL, Wilgus A, Slawson DC. Diagnosis and management of endometriosis. Am Fam Phys 2006;74:594–600
- Bulun SE. Endometriosis. N Engl J Med 2009;360:268–79
- Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril 1997;67:817–21
- Brosens I, Puttemans P, Campo R, et al. Diagnosis of endometriosis: pelvic endoscopy and imaging techniques. Best Pract Res Clin Obstet Gynaecol 2004;18:285–303
- Mol BW, Bayram N, Lijmer JG, et al. The performance of CA-125 measurement in the detection of endometriosis: a meta-analysis. Fertil Steril 1998;70:1101–8
- Hadfield R, Mardon H, Barlow D, Kennedy S. Delay in the diagnosis of endometriosis: a survey of women from the USA and the UK. Hum Reprod 1996;11:878–80
- D’Hooghe T, Hummelshoj L. Multi-disciplinary centres/networks of excellence for endometriosis management and research: a proposal. Hum Reprod 2006;21:2743–8
- Tokushige N, Markham R, Crossett B, et al. Discovery of a novel biomarker in the urine in women with endometriosis. Fertil Steril 2011;95:46–9
- Moll R, Franke WW, Schiller DL, et al. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982;31:11–24
- Gion M, Mione R, Barioli P, et al. The correlation between serum levels of cytokeratin tumor markers does reflect their molecular characterization. Int J Biol Markers 1994;9:121–2
- Sundstrom BE, Stigbrand TI. Cytokeratins and tissue polypeptide antigen. Int J Biol Markers 1994;9:102–8
- Novaes M, Bendit I, Garicochea B, del Giglio A. Reverse transcriptase-polymerase chain reaction analysis of cytokeratin 19 expression in the peripheral blood mononuclear cells of normal female blood donors. Mol Pathol 1997;50:209–11
- Pujol JL, Grenier J, Daures JP, et al. Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer. Cancer Res 1993;53:61–6
- Yamamoto K, Oka M, Hayashi H, et al. CYFRA 21-1 is a useful marker for esophageal squamous cell carcinoma. Cancer 1997;79:1647–55
- Tempfer CB, Bancher-Todesca D, Zeisler H, et al. Placental expression and serum concentrations of cytokeratin 19 in preeclampsia. Obstet Gynecol 2000;95:677–82
- Bartek J, Bartkova J, Taylor-Papadimitriou J, et al. Differential expression of keratin 19 in normal human epithelial tissues revealed by monospecific monoclonal antibodies. Histochem J 1986;18:565–75
- van der Linden PJ, Dunselman GA, de Goeij AF, et al. Epithelial cells in peritoneal fluid – of endometrial origin? Am J Obstet Gynecol 1995;173:566–70
- Tempfer C, Hefler L, Heinzl H, et al. CYFRA 21-1 serum levels in women with adnexal masses and inflammatory diseases. Br J Cancer 1998;78:1108–12
- Prinz F, Schlange T, Asadullah K. Believe it or not: how much can we rely on published data on potential drug targets? Nat Rev Drug Discov 2011;10:328--9
- May KE, Conduit-Hulbert SA, Villar J, et al. Peripheral biomarkers of endometriosis: a systematic review. Hum Reprod Update 2010;16:651–74